BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Baj J, Forma A, Sitarz M, Portincasa P, Garruti G, Krasowska D, Maciejewski R. Helicobacter pylori Virulence Factors-Mechanisms of Bacterial Pathogenicity in the Gastric Microenvironment. Cells 2020;10:E27. [PMID: 33375694 DOI: 10.3390/cells10010027] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 8.5] [Reference Citation Analysis]
Number Citing Articles
1 Choe AR, Shim KN, Park Y, Song EM, Tae CH, Jung SA. Cost-Effectiveness, Efficacy, and Safety Analysis of Tailored Therapy in Patients with Helicobacter pylori Infection. J Clin Med 2021;10:2619. [PMID: 34198677 DOI: 10.3390/jcm10122619] [Reference Citation Analysis]
2 Charitos IA, D’agostino D, Topi S, Bottalico L. 40 Years of Helicobacter pylori: A Revolution in Biomedical Thought. Gastroenterology Insights 2021;12:111-35. [DOI: 10.3390/gastroent12020011] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
3 Cardos AI, Maghiar A, Zaha DC, Pop O, Fritea L, Miere (Groza) F, Cavalu S. Evolution of Diagnostic Methods for Helicobacter pylori Infections: From Traditional Tests to High Technology, Advanced Sensitivity and Discrimination Tools. Diagnostics 2022;12:508. [DOI: 10.3390/diagnostics12020508] [Reference Citation Analysis]
4 de Brito BB, Lemos FFB, Carneiro CDM, Viana AS, Barreto NMPV, Assis GAS, Braga BDC, Santos MLC, Silva FAFD, Marques HS, Silva NOE, de Melo FF. Immune response to Helicobacter pylori infection and gastric cancer development. World J Meta-Anal 2021; 9(3): 257-276 [DOI: 10.13105/wjma.v9.i3.257] [Reference Citation Analysis]
5 Klang E, Soffer S, Barash Y, Shachar E, Lahat A. Changes in Helicobacter pylori Treatment from Discovery to Nowadays: A High-Level Analysis of PubMed Publications. CEG 2022;Volume 15:51-8. [DOI: 10.2147/ceg.s342048] [Reference Citation Analysis]
6 Keikha M, Namdar AB. The presence of DupA and clarithromycin resistance in H. pylori among patients with peptic ulcer disease; a rational connection. Gene Reports 2022;26:101508. [DOI: 10.1016/j.genrep.2022.101508] [Reference Citation Analysis]
7 Dabral D, van den Bogaart G. The Roles of Phospholipase A2 in Phagocytes. Front Cell Dev Biol 2021;9:673502. [PMID: 34179001 DOI: 10.3389/fcell.2021.673502] [Reference Citation Analysis]
8 Sharndama HC, Mba IE. Helicobacter pylori: an up-to-date overview on the virulence and pathogenesis mechanisms. Braz J Microbiol 2022. [PMID: 34988937 DOI: 10.1007/s42770-021-00675-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 7.0] [Reference Citation Analysis]
9 Shi Y, Zheng H, Wang M, Ding S. Influence of Helicobacter pylori infection on PD-1/PD-L1 blockade therapy needs more attention. Helicobacter 2022;:e12878. [PMID: 35112435 DOI: 10.1111/hel.12878] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Tilahun M, Gedefie A, Belayhun C, Sahle Z, Abera A. Helicobacter pylori Pathogenicity Islands and Giardia lamblia Cysteine Proteases in Role of Coinfection and Pathogenesis. Infect Drug Resist 2022;15:21-34. [PMID: 35023934 DOI: 10.2147/IDR.S346705] [Reference Citation Analysis]
11 Alexander SM, Retnakumar RJ, Chouhan D, Devi TNB, Dharmaseelan S, Devadas K, Thapa N, Tamang JP, Lamtha SC, Chattopadhyay S. Helicobacter pylori in Human Stomach: The Inconsistencies in Clinical Outcomes and the Probable Causes. Front Microbiol 2021;12:713955. [PMID: 34484153 DOI: 10.3389/fmicb.2021.713955] [Reference Citation Analysis]
12 Lu Q, Zhang Z, Xu Y, Chen Y, Li C. Sanguinarine, a major alkaloid from Zanthoxylum nitidum (Roxb.) DC., inhibits urease of Helicobacter pylori and jack bean: Susceptibility and mechanism. J Ethnopharmacol 2022;:115388. [PMID: 35577159 DOI: 10.1016/j.jep.2022.115388] [Reference Citation Analysis]
13 Lu SY, Guo S, Chai SB, Yang JQ, Yue Y, Li H, Sun PM, Zhang T, Sun HW, Zhou JL, Yang JW, Yang HM, Li ZP, Cui Y. Autophagy in Gastric Mucosa: The Dual Role and Potential Therapeutic Target. Biomed Res Int 2021;2021:2648065. [PMID: 34195260 DOI: 10.1155/2021/2648065] [Reference Citation Analysis]
14 Săsăran MO, Meliț LE, Dobru ED. MicroRNA Modulation of Host Immune Response and Inflammation Triggered by Helicobacter pylori. Int J Mol Sci 2021;22:1406. [PMID: 33573346 DOI: 10.3390/ijms22031406] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Matzhold EM, Berghold A, Bemelmans MKB, Banfi C, Stelzl E, Kessler HH, Steinmetz I, Krause R, Wurzer H, Schlenke P, Wagner T. Lewis and ABO histo-blood types and the secretor status of patients hospitalized with COVID-19 implicate a role for ABO antibodies in susceptibility to infection with SARS-CoV-2. Transfusion 2021. [PMID: 34151460 DOI: 10.1111/trf.16567] [Reference Citation Analysis]
16 Baj J, Forma A, Dudek I, Chilimoniuk Z, Dobosz M, Dobrzyński M, Teresiński G, Buszewicz G, Flieger J, Portincasa P. The Involvement of Human Papilloma Virus in Gastrointestinal Cancers. Cancers (Basel) 2022;14:2607. [PMID: 35681587 DOI: 10.3390/cancers14112607] [Reference Citation Analysis]
17 Mazzei L, Massai L, Cianci M, Messori L, Ciurli S. Medicinal Au(I) compounds targeting urease as prospective antimicrobial agents: unveiling the structural basis for enzyme inhibition. Dalton Trans 2021;50:14444-52. [PMID: 34585201 DOI: 10.1039/d1dt02488d] [Reference Citation Analysis]
18 Jin F, Yang H. Complete Genome Sequence of Helicobacter pylori Strain 3192, Isolated from a Chinese Patient with Chronic Nonatrophic Gastritis. Microbiol Resour Announc 2022;:e0038222. [PMID: 35652651 DOI: 10.1128/mra.00382-22] [Reference Citation Analysis]
19 Do AD, Su CH, Hsu YM. Antagonistic Activities of Lactobacillus rhamnosus JB3 Against Helicobacter pylori Infection Through Lipid Raft Formation. Front Immunol 2021;12:796177. [PMID: 35095872 DOI: 10.3389/fimmu.2021.796177] [Reference Citation Analysis]
20 Zou Y, Chen X, Sun Y, Li P, Xu M, Fang P, Zhang S, Yuan G, Deng X, Hu H. Antibiotics-free nanoparticles eradicate Helicobacter pylori biofilms and intracellular bacteria. J Control Release 2022;348:370-85. [PMID: 35662575 DOI: 10.1016/j.jconrel.2022.05.044] [Reference Citation Analysis]
21 Mahant S, Mehra S, Chhawchharia A, Karmakar BC, Paul S, Mukhopadhyay AK, Bose S, Das K, Das R. Prevalence of tumor necrosis factor alpha inducing protein (tipα) gene of Helicobacter pylori and its association with upper gastrointestinal diseases in India. 3 Biotech 2021;11:246. [PMID: 33968589 DOI: 10.1007/s13205-021-02804-w] [Reference Citation Analysis]
22 Kohoutova D, Banks M, Bures J. Advances in the Aetiology & Endoscopic Detection and Management of Early Gastric Cancer. Cancers (Basel) 2021;13:6242. [PMID: 34944861 DOI: 10.3390/cancers13246242] [Reference Citation Analysis]
23 Sijmons D, Guy AJ, Walduck AK, Ramsland PA. Helicobacter pylori and the Role of Lipopolysaccharide Variation in Innate Immune Evasion. Front Immunol 2022;13:868225. [DOI: 10.3389/fimmu.2022.868225] [Reference Citation Analysis]
24 Sathianarayanan S, V A, Biswas R, B A, Sukumaran S, Venkidasamy B. A new approach against Helicobacter pylori using plants and its constituents: A review study. Microbial Pathogenesis 2022. [DOI: 10.1016/j.micpath.2022.105594] [Reference Citation Analysis]
25 Padda J, Khalid K, Cooper AC, Jean-Charles G. Association Between Helicobacter pylori and Gastric Carcinoma. Cureus 2021;13:e15165. [PMID: 34168929 DOI: 10.7759/cureus.15165] [Reference Citation Analysis]
26 El-sherbiny GM, Elbestawy MKM. A review – plant essential oils active against Helicobacter pylori. Journal of Essential Oil Research. [DOI: 10.1080/10412905.2022.2025464] [Reference Citation Analysis]
27 Mestrovic A, Bozic J, Vukojevic K, Tonkic A. Impact of Different Helicobacter pylori Eradication Therapies on Gastrointestinal Symptoms. Medicina (Kaunas) 2021;57:803. [PMID: 34441009 DOI: 10.3390/medicina57080803] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Forma A, Chilimoniuk Z, Januszewski J, Sitarz R. The Potential Application of Allium Extracts in the Treatment of Gastrointestinal Cancers. Gastroenterology Insights 2021;12:136-46. [DOI: 10.3390/gastroent12020012] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
29 Aydın EM, Demir TD, Seymen N, Said SS, Oktem-Okullu S, Tiftikci A, Cicek B, Tokat F, Tozun N, Ince U, Sezerman U, Sayi-Yazgan A. The crosstalk between H. pylori virulence factors and the PD1:PD-L1 immune checkpoint inhibitors in progression to gastric cancer. Immunol Lett 2021;239:1-11. [PMID: 34363898 DOI: 10.1016/j.imlet.2021.06.009] [Reference Citation Analysis]
30 Ariyoshi T, Hagihara M, Takahashi M, Mikamo H. Effect of Clostridium butyricum on Gastrointestinal Infections. Biomedicines 2022;10:483. [PMID: 35203691 DOI: 10.3390/biomedicines10020483] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
31 Baj J, Forma A, Flieger W, Morawska I, Michalski A, Buszewicz G, Sitarz E, Portincasa P, Garruti G, Flieger M, Teresiński G. Helicobacter pylori Infection and Extragastric Diseases-A Focus on the Central Nervous System. Cells 2021;10:2191. [PMID: 34571840 DOI: 10.3390/cells10092191] [Reference Citation Analysis]
32 Liao Y, Chen W, Shi W, Zha H. Targeting cPLA2α inhibits gastric cancer and augments chemotherapy efficacy via suppressing Ras/MEK/ERK and Akt/β-catenin pathways. Cancer Chemother Pharmacol 2021;88:689-97. [PMID: 34255137 DOI: 10.1007/s00280-021-04322-1] [Reference Citation Analysis]